Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LC-MS-based quantitation of proteomic changes induced by Norcantharidin in MTB-Treated macrophages. | Proteome Sci | 2024 | 39633431 | PubTator, text mining | PubMed |
| VAV1 regulates cell growth in cutaneous T-cell lymphoma via the BAMBI/BMF signalling pathway. | Eur J Dermatol | 2024 | 39589030 | PubTator, text mining | PubMed |
| Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis. | Nature | 2024 | 39478228 | PubTator, text mining | PubMed |
| LYP regulates SLP76 and other adaptor proteins in T cells. | Biol Res | 2024 | 39342392 | PubTator, text mining | PubMed |
| Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis. | Protein Pept Lett | 2024 | 39301900 | PubTator, text mining | PubMed |
| NADPH oxidase 1/4 dual inhibitor setanaxib suppresses platelet activation and thrombus formation. | Life Sci | 2024 | 39293714 | PubTator, text mining | PubMed |
| CD11b-NOX2 mutual regulation-mediated microglial exosome release contributes to rotenone-induced inflammation and neurotoxicity in BV2 microglia and primary cultures. | Free Radic Biol Med | 2024 | 39265792 | PubTator, text mining | PubMed |
| Prognostic Significance of VAV3 Gene Variants and Expression in Renal Cell Carcinoma. | Biomedicines | 2024 | 39200159 | PubTator, text mining | PubMed |
| Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses. | Sci Rep | 2024 | 39169044 | PubTator, text mining | PubMed |
| Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals. | BMC Res Notes | 2024 | 39127702 | PubTator, text mining | PubMed |
| VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases. | Trends Immunol | 2024 | 39060140 | PubTator, text mining | PubMed |
| Identification of Immune Infiltrating Cell-Related Biomarkers in Early Gastric Cancer Progression. | Technol Cancer Res Treat | 2024 | 38860335 | PubTator, text mining | PubMed |
| Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology. | BMC Complement Med Ther | 2024 | 38858650 | PubTator, text mining | PubMed |
| Correlation between elevated HCLS1 levels and heart failure: A diagnostic biomarker. | Medicine (Baltimore) | 2024 | 38847679 | PubTator, text mining | PubMed |
| of Potential Noncoding RNAs Related to Spinal Cord Injury Based on Competing Endogenous RNAs. | Mol Neurobiol | 2024 | 38809369 | PubTator, text mining | PubMed |
| Presynaptic structural and functional plasticity are coupled by convergent Rap1 signaling. | J Cell Biol | 2024 | 38748250 | PubTator, text mining | PubMed |
| Proteomic Analysis of Prehypertensive and Hypertensive Patients: Exploring the Role of the Actin Cytoskeleton. | Int J Mol Sci | 2024 | 38732116 | PubTator, text mining | PubMed |
| Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis. | Int J Mol Sci | 2024 | 38673990 | PubTator, text mining | PubMed |
| Rapid and accurate remethylation of DNA in Dnmt3a-deficient hematopoietic cells with restoration of DNMT3A activity. | Sci Adv | 2024 | 38295174 | PubTator, text mining | PubMed |
| Revealing third-order interactions through the integration of machine learning and entropy methods in genomic studies. | BioData Min | 2024 | 38291454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=4